Is the biotech job market improving in 2025? Explore the latest trends and opportunities in the industry after a challenging ...

Listen to this article Mark T. Esser, vice president for vaccines and immune therapies at pharmaceutical giant AstraZeneca, will be the inaugural chief scientific officer and leader of the Paul and ...

UNC Pembroke is offering a free, two-week bioprocessing training course to help students and community members prepare for ...

The number of employees laid off dropped year over year during the first quarter. BioSpace recaps the five largest layoffs, ...

VQ Biomedical, spun out of Duke University, has developed a novel, minimally invasive catheter designed to deliver oxygen directly to the bloodstream. The catheter bypasses the lungs, giving ARDS ...

On The Readout LOUD podcast, STAT reporters talk about new FDA commissioner Marty Makary's first week amid a swirl of layoffs ...

Robert F. Kennedy Jr. is the new Health Secretary. From fluoride, vaccines and beef tallow, here's how he might "go wild" on ...

Tariffs and federal research “uncertainty” are forcing a Peninsula company to lay off workers at headquarters and cut other costs.

Shuren, who retired from his spot leading the FDA’s Center for Devices and Radiological Health (CDRH) in 2024, said last week ...

Immunovant Inc. is accused of discriminatory hiring due to the use of artificial intelligence in the hiring process. But one ...

Fanitsyara Kam Phon says public universities tend only to react to the government’s lead when developing STEM courses, ...

Freezes and reductions in National Institutes of Health funding are reverberating beyond universities and research labs to startups in the biotech industry.